Molecular classification and prognostication of 300 node-negative breast cancer cases: A tertiary care experience

Shemin, K M Zuhara; Smitha, N V; Jojo, Annie; Vijaykumar, Dehannathparambil Kottarathil

doi:10.4103/2278-330x.175952

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Luminal A is the most common molecular subtype of breast cancer with a relatively good prognosis. Endocrine therapy is the preferred treatment option for luminal A breast cancer since the tumor is hormone receptor-positive [ 4 ]. However, several genetic factors determine the efficacy of endocrine therapy for luminal A breast cancer.…”

Section: Introductionmentioning

confidence: 99%

Identification of key genes unique to the luminal a and basal-like breast cancer subtypes via bioinformatic analysis

Jia

Liang

et al. 2020

World J Surg Onc

View full text Add to dashboard Cite

Background Breast cancer subtypes are statistically associated with prognosis. The search for markers of breast tumor heterogeneity and the development of precision medicine for patients are the current focuses of the field. Methods We used a bioinformatic approach to identify key disease-causing genes unique to the luminal A and basal-like subtypes of breast cancer. First, we retrieved gene expression data for luminal A breast cancer, basal-like breast cancer, and normal breast tissue samples from The Cancer Genome Atlas database. The differentially expressed genes unique to the 2 breast cancer subtypes were identified and subjected to Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. We constructed protein–protein interaction networks of the differentially expressed genes. Finally, we analyzed the key modules of the networks, which we combined with survival data to identify the unique cancer genes associated with each breast cancer subtype. Results We identified 1114 differentially expressed genes in luminal A breast cancer and 1042 differentially expressed genes in basal-like breast cancer, of which the subtypes shared 500. We observed 614 and 542 differentially expressed genes unique to luminal A and basal-like breast cancer, respectively. Through enrichment analyses, protein–protein interaction network analysis, and module mining, we identified 8 key differentially expressed genes unique to each subtype. Analysis of the gene expression data in the context of the survival data revealed that high expression of NMUR1 and NCAM1 in luminal A breast cancer statistically correlated with poor prognosis, whereas the low expression levels of CDC7, KIF18A, STIL, and CKS2 in basal-like breast cancer statistically correlated with poor prognosis. Conclusions NMUR1 and NCAM1 are novel key disease-causing genes for luminal A breast cancer, and STIL is a novel key disease-causing gene for basal-like breast cancer. These genes are potential targets for clinical treatment.

show abstract

Section: Introductionmentioning

confidence: 99%